We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

106 hedge funds and large institutions have $13.5M invested in Sanofi Contingent Value Rights in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $12.6M → $13.5M (+$914K)

7% less funds holding

Funds holding: 114 → 106 (-8)

22% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 18

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

50% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 16

Holders
106
Holders Change
-8
Holders Change %
-7.02%
% of All Funds
2.82%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
8
Increased
14
Reduced
18
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$581K
2
MFP
Michael F. Price
+$205K
3
CL
CSS LLC
Illinois
+$84K
4
TL
TowerView LLC
New York
+$32.3K
5
FCM
Farallon Capital Management
California
+$27K

Top Sellers

Rank Fund Capital Flow
1
SAM
Silverback Asset Management
North Carolina
-$97K
2
ACM
Akanthos Capital Management
California
-$75K
3
Citadel Advisors
Citadel Advisors
Florida
-$31K
4
PC
Permanens Capital
New York
-$13K
5
ZIG
Zuckerman Investment Group
Illinois
-$6.16K
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
26
Farallon Capital Management
California
$28K +$27K +248,695 New
TI
27
Telemetry Investments
New York
$23K – – –
YCM
28
Yakira Capital Management
Connecticut
$18K – – –
UBS Group
29
UBS Group
Switzerland
$17K -$2.51K -23,158 -13%
First Eagle Investment Management
30
First Eagle Investment Management
New York
$17K – – –
LCM
31
Lonestar Capital Management
California
$17K – – –
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$15K +$7.18K +66,259 +107%
EEG
33
E.E. Geduld
$14K – – –
PP
34
Paloma Partners
Connecticut
$11K – – –
IRF
35
IBM Retirement Fund
New York
$8K – – –
JP Morgan Chase
36
JP Morgan Chase
New York
$7K -$3.7K -34,170 -35%
GI
37
GAMCO Investors
Connecticut
$7K -$87 -800 -1%
Wells Fargo
38
Wells Fargo
California
$7K +$60 +554 +0.9%
OCM
39
Osterweis Capital Management
California
$6K – – –
ZIG
40
Zuckerman Investment Group
Illinois
$5K -$6.16K -56,791 -56%
Korea Investment Corp
41
Korea Investment Corp
South Korea
$5K – – –
Commonwealth Equity Services
42
Commonwealth Equity Services
Massachusetts
$5K +$6 +54 +0.1%
CHAM
43
Clear Harbor Asset Management
Connecticut
$4K – – –
WHI
44
William Harris Investors
Illinois
$4K – – –
Morgan Stanley
45
Morgan Stanley
New York
$3K -$1.35K -12,461 -29%
SDWMA
46
Schneider Downs Wealth Management Advisors
Pennsylvania
$3K – – –
PP
47
Pegasus Partners
Wisconsin
$2K -$2.17K -20,000 Closed
LPL Financial
48
LPL Financial
California
$2K -$151 -1,390 -7%
CS
49
Credit Suisse
Switzerland
$2K -$95 -880 -5%
PNC Financial Services Group
50
PNC Financial Services Group
Pennsylvania
$2K -$45 -412 -3%
1
2
3 4

GCVRZ Hedge Fund Activity: Q1 2016 in Review

106 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2016, worth a combined $13.5M — up 7.2% from $12.6M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 8 opened new positions — a net loss of 8 holders — while 18 trimmed existing stakes and 14 added.

The largest buyer was Stonehill Capital Management, adding an estimated $581K. The largest seller was Silverback Asset Management, exiting entirely with an estimated $97K sold.

  • 106 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2016, down from 114 in Q4 2015.
  • Funds reported $13.5M of Sanofi Contingent Value Rights stock for Q1 2016, up 7.2% quarter-over-quarter.
  • 8 funds opened new Sanofi Contingent Value Rights positions in Q1 2016 and 16 closed out, a net change of -8 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2016 was Stonehill Capital Management, an estimated $581K added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2016 was Silverback Asset Management, an estimated $97K sold.

Based on aggregated 13F filings for Q1 2016.